SCHEMBL520268

SCHEMBL520268

C1=Cc2ccccc2CCN1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.61
HTR2C P28335 2/20 0.44
MAOB P27338 3/20 0.40
PNMT P11086 1/20 0.40
CD44 P16070 1/20 0.40
PRCP P42785 5/20 0.37
GAA P10253 1/20 0.36
PDPK1 O15530 1/20 0.35
PARP10 Q53GL7 1/20 0.35
PARP11 Q9NR21 1/20 0.35
NISCH Q9Y2I1 1/20 0.35
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
HTR2A P28223 1/20 0.32
HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28167488 0.77 PARP1 (0.95) PARP1HTR2CMAOBPNMTCD44
SCHEMBL19579719 0.77 HTR2C (0.48) PARP1HTR2CMAOBPNMTCD44
SCHEMBL33931 0.77 PARP1 (0.95) PARP1HTR2CMAOBPNMTCD44
SCHEMBL29429329 0.77 PARP1 (0.95) PARP1HTR2CMAOBPNMTCD44
1,2,3,4-Tetrahydroisoquinoline SCHEMBL22363225 0.76 PARP1 (0.68) PARP1HTR2CMAOBPNMTCD44
Bromide SCHEMBL19031040 0.76 PARP1 (0.91) PARP1HTR2CMAOBPNMTCD44
Hydrochloric Acid SCHEMBL7007870 0.76 PARP1 (1.00) PARP1HTR2CMAOBPNMTCD44
Hydrochloric Acid SCHEMBL27599345 0.76 PARP1 (1.00) PARP1HTR2CMAOBPNMTCD44
Bromide SCHEMBL7236242 0.76 PARP1 (0.91) PARP1HTR2CMAOBPNMTCD44
SCHEMBL28243677 0.76 PARP1 (0.91) PARP1HTR2CMAOBPNMTCD44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347672-B1 Benzazepine derivatives NOVO NORDISK AS (DK) 1994-03-02 EP claimed
EP-0080012-B1 6-CHLORO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE, ITS ACID ADDITION SALTS AND ITS USE AS AN INTERMEDIATE SMITHKLINE BECKMAN CORPORATION (US) 1986-04-09 EP claimed
EP-0160513-A1 Fenoldopam 4', 8-bis-hydrogen sulfates SMITHKLINE BECKMAN CORPORATION (US) 1985-11-06 EP claimed
EP-2934118-B1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2018-01-31 EP disclosed
US-20170158597-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2017-06-08 US disclosed
US-9630910-B2 Pesticidal compositions and processes related thereto DOW AGROSCIENCES LLC (US) 2017-04-25 US disclosed
US-20160037771-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2016-02-11 US disclosed
US-9212164-B2 Pesticidal compositions and processes related thereto DOW AGROSCIENCES LLC (US) 2015-12-15 US disclosed
US-9006231-B2 Cephalotaxus esters, methods of synthesis, and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-04-14 US disclosed
EP-2376491-B1 PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS CEPHALON INC (US) 2015-03-04 EP disclosed
US-20140171416-A1 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2014-06-19 US disclosed
WO-2009148654-A2 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2009-12-10 WO disclosed
EP-1589014-A1 Process for the preparation of 1,3-dihydro-2H-3-benzazepin-2-one and application to the preparation of ivabradine and their pharmaceutically acceptable salts Les Laboratoires Servier (FR) 2005-10-26 EP disclosed
EP-0628030-B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES SCHERING CORP (US) 2002-12-11 EP disclosed
EP-1011679-A1 USE OF 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SLEEP DISORDERS CeNes Limited (GB) 2000-06-28 EP disclosed
EP-0351733-B1 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines in the treatment of neurological disorders SCHERING CORP (US) 1995-12-06 EP disclosed
US-5455348-A Anticoagulants Thomae, Karl (DE) 1995-10-03 US disclosed
EP-0628030-A1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES SCHERING CORPORATION (US) 1994-12-14 EP disclosed
EP-0351733-A1 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines in the treatment of neurological disorders SCHERING CORPORATION (US) 1990-01-24 EP disclosed
EP-0005299-A1 Substituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for the preparation thereof, and pharmaceutical compositions containing them Technobiotic Ltd. (CH) 1979-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158597-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO ACHE, DDT, PTMS PARP1 4069/4885HTR2C 3279/4885MAOB 1013/4885
US-20160037771-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO ACHE, DDT, PTMS PARP1 4069/4885HTR2C 3279/4885MAOB 1013/4885
US-20140171416-A1 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF COASY, CXCR4, CETP PARP1 587/4885HTR2C 4799/4885MAOB 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.